Literature DB >> 17401835

The production of acetate derived hydroxyanthraquinones, -dianthrones, -naphthalenes and -benzenes in tissue cultures from Rumex alpinus.

A J van den Berg1, R P Labadie.   

Abstract

Tissue cultures set up from roots of Rumex alpinus L. were grown on Murashige and Skoog's medium with kinetin and either 2,4-D or NAA as growth factors. The 2,4-D cultures produced a broader spectrum of hydroxyanthracene, hydroxynaphthalene and hydroxybenzene derivatives than the NAA cultures. In the 2,4-D cultures the anthraquinones chrysophanol, physcion and emodin, the dianthrones of chrysophanol and physcion and their heterodianthrone and the monoglucoside of chrysophanol were identified. Also the naphthaiene-1,8-diols nepodin, nepodinmonoglucoside and methoxynepodin have been identified. The occurrence of 2-acetylorcinol and its monoglucoside was also established. In the NAA cultures accumulation of only chrysophanol, physcion and 2-acetylorcinol could be proved. The yields of these secondary metabolites produced in the NAA cultures were determined to be much lower than those produced by the 2,4-D cultures.

Entities:  

Year:  1981        PMID: 17401835     DOI: 10.1055/s-2007-971695

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  3 in total

Review 1.  The genus Rumex (Polygonaceae): an ethnobotanical, phytochemical and pharmacological review.

Authors:  Jing-Juan Li; Yong-Xiang Li; Na Li; Hong-Tao Zhu; Dong Wang; Ying-Jun Zhang
Journal:  Nat Prod Bioprospect       Date:  2022-06-16

2.  Influence of acetate and malonate on the production of 1,8-dihydroxyanthracene derivatives in suspension cultures ofRhamnus purshiana.

Authors:  A J van den Berg; M H Radema; R P Labadie
Journal:  Planta       Date:  1988-06       Impact factor: 4.116

3.  Polygonumnolides A1-B3, minor dianthrone derivatives from the roots of Polygonum multiflorum Thunb.

Authors:  Jianbo Yang; Zheng Yan; Jin Ren; Zhong Dai; Shuangcheng Ma; Aiguo Wang; Yalun Su
Journal:  Arch Pharm Res       Date:  2017-07-05       Impact factor: 4.946

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.